NUTX vs PATH
Nutex Health Inc (NUTX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Nutex Health Inc (NUTX) is a medical care facilities company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported NUTX revenue for 2024-12-31 was $257.6M. Net income was $100.0M. Revenue was up 269.8% from 2023-12-31 to 2024-12-31. NUTX currently screens at market cap $995.0M and trailing P/E 10.6.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
NUTX currently screens at market cap $995.0M and trailing P/E 10.6. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the NUTX and PATH stock pages for the full models.
Not investment advice.